{"id":997902,"date":"2026-08-25T10:18:15","date_gmt":"2026-08-25T14:18:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/"},"modified":"2026-08-25T10:18:15","modified_gmt":"2026-08-25T14:18:15","slug":"podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/","title":{"rendered":"PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit &#8211; Contact SueWallSt"},"content":{"rendered":"<h2>\nInsulet Promoted Its Manufacturing Quality and Omnipod 5 Growth \u2014 Then Two Recalls Affecting 7 Million Pods Revealed Alleged Manufacturing Deficiencies<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>NEW YORK, Aug.  25, 2026  (GLOBE NEWSWIRE) &#8212; SueWallSt notifies investors of an investigation into Insulet Corporation (NASDAQ: PODD). On one side: a CEO declaring Insulet produced &#8220;tens of millions of Pods with high-quality medical-grade quality at consumer electronic scale.&#8221; On the other: approximately 7 million Pods subject to Medical Device Corrections after manufacturing issues created risks of insulin under-delivery, while shareholders watched PODD plummet from $236 to $146 per share.<\/p>\n<p>Insulet&#8217;s stock declined approximately $24 per share cumulatively following the two corrective disclosures. The lead plaintiff deadline is August 31, 2026. <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JOKWlzvCTbYthLtP1IMJKs3ImizgH88IXRpEw6cBI0v1H4Q6KPZK-d9VgmezS1kyt4HF2ypkHBLd-0asHF0PauhHv1DDL5Oov64-Kjq457DgefebIdJ19L05PXndIduL9N7I3hTh88TXYa9yheVjCJiWBWqhOC2wwO6UxyM6GLO6Qicyss16Z_CP7n7844GyUZnp1ICVnmoV_Y1f-cEvsVAZ1CRN0KvixVy1yX0BXd4=\" rel=\"nofollow\" target=\"_blank\"><u>Find out if you could qualify to recover your losses<\/u><\/a>. You may also contact Joseph E. Levi, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=18wAJnaBIkppiiTucLWTVyIegPX9omgfCUpQZ__9EW3S1u2xh2g7Kz4KNjA7eqM6A8nuR5IuC9XdYP46yVwu6dNbgwJ2ENzDsZxPRUwEP1s=\" rel=\"nofollow\" target=\"_blank\"><u>jlevi@SueWallSt.com<\/u><\/a> or (888) SueWallSt.<\/p>\n<p>\n        <strong>The Promise<\/strong>\n      <\/p>\n<p>Throughout 2025 and into early 2026, the Company&#8217;s leadership projected an image of manufacturing excellence. During the FY 2024 earnings call, management stated it had taken &#8220;years to build a patch pump product at scale with quality, high yield, safety.&#8221; By August 2025, the message escalated: the Company had &#8220;pioneered advanced automation&#8221; and built a &#8220;robust and secure global supply chain to deliver tens of millions of complex electromechanical devices per year at medical standards.&#8221; In February 2026, management declared the Company produced pods &#8220;with high-quality medical-grade quality at consumer electronic scale&#8221; and pointed to improving productivity at its Acton, Massachusetts facility.<\/p>\n<p>SEC filings reinforced the narrative, with the Company&#8217;s FY 2024 and FY 2025 10-K filings both stating that its Quality team &#8220;inspects and tests our products at various steps in the manufacturing cycle to facilitate compliance with our specifications.&#8221;<\/p>\n<p>\n        <strong>The Reality<\/strong>\n      <\/p>\n<p>The complaint alleges these assurances concealed deficient manufacturing controls at the Acton facility:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-top:2pt;margin-bottom:2pt\">\n          <strong>March 12, 2026:<\/strong> Insulet initiated its first voluntary Medical Device Correction for Omnipod 5 Pods after identifying pods with &#8220;a small tear in the internal tubing that delivers insulin.&#8221; PODD fell $16.23 per share (6.88%) the next trading day.<\/li>\n<li style=\"margin-top:2pt;margin-bottom:2pt\">\n          <strong>May 26, 2026:<\/strong> A second, far larger MDC covered Omnipod 5, Omnipod Dash, and legacy Omnipod Eros Pods. Approximately 7 million Pods were affected, representing 8.5% of 2025 global production. PODD dropped another $7.79 per share (5.07%).<\/li>\n<li style=\"margin-top:2pt;margin-bottom:2pt\">Both MDCs stemmed from the same root cause: &#8220;cannula tears associated with cannula handling at the Company&#8217;s Acton, Massachusetts facility.&#8221;<\/li>\n<li style=\"margin-top:2pt;margin-bottom:2pt\">After the first recall, management characterized the problem as affecting &#8220;only a very small number of pods&#8221; and assured investors that non-recalled pods were &#8220;very safe to use.&#8221; Two months later, 7 million more pods were recalled for the identical defect.\n<\/li>\n<\/ul>\n<p>\n        <strong>The Numbers: Promised vs. Actual<\/strong>\n      <\/p>\n<table style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">\n            <strong>What Was Promised<\/strong>\n          <\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">\n            <strong>What Actually Happened<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">&#8220;High-quality medical-grade quality at consumer electronic scale&#8221;<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Two MDCs disclosed manufacturing issues affecting Omnipod products and raised concerns regarding quality-control processes<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Quality team &#8220;inspects and tests&#8221; at &#8220;various steps&#8221;<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Cannula tears went undetected across multiple product lines<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">March MDC affected &#8220;only a very small number of pods&#8221; (1.5%)<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">May MDC affected approximately 7 million pods (8.5% of annual production)<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">&#8220;All other Omnipod products remain safe to use&#8221;<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Second MDC expanded to Omnipod Dash and Omnipod Eros<\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Gross margin anticipated to increase due to &#8220;improved manufacturing efficiencies&#8221;<\/td>\n<td style=\"border-top: solid black 1pt;border-right: solid black 1pt;border-bottom: solid black 1pt;border-left: solid black 1pt;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: top\">Following the corrective disclosures, analysts raised concerns regarding manufacturing execution and the impact on the company&#8217;s guidance<\/td>\n<\/tr>\n<\/table>\n<p>\n        <strong><br \/>\n          <br \/>What the Lawsuit Alleges About the Gap<\/strong>\n      <\/p>\n<p>The securities action contends that the Company&#8217;s manufacturing controls were deficient throughout the Class Period, and that management knew or recklessly disregarded this reality while making public assurances about quality and safety. BTIG reduced its valuation multiple from approximately 4.5x to 4x, citing &#8220;continued negative investor sentiment&#8221; and &#8220;risk of reputation damage.&#8221; Goldman Sachs wrote that &#8220;referencing back to the March MDC&#8221; did not &#8220;sufficiently capture the magnitude of the quality issues.&#8221;<\/p>\n<p>\n        <em>&#8220;Companies that make specific promises to investors about future performance have an obligation to disclose known risks to those projections. The contrast between Insulet&#8217;s repeated manufacturing quality assurances and the scope of the resulting recalls raises serious questions for shareholders.&#8221;<\/em> \u2014 Joseph E. Levi, Esq.<\/p>\n<p>LEAD PLAINTIFF DEADLINE: August 31, 2026<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=tc1snxMJCc1wDUwXnIY3l8Q7DIuhc1Di-tEnrId5T0C_3-8C8T9HYmgs3sgfZS2cTD0gcy_oHcD7zR9-EH_pdynjvx-BG3Ve7NjyYRbV4Ntg5q6S3ehJNOX3Sz5ErTkUmg63UN_K1ec0skhIAfN594TnnIn3AfHEWac1FvMrW0x4NfYmOgS7ETdodgXOHbqPPsdsIg1PnPuYj5ICImgZ5w==\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <u>Submit your information here<\/u><br \/>\n        <\/a> or call (888) SueWallSt.<\/p>\n<p>\n        <strong>WHY SUEWALLST:<\/strong> SueWallSt is powered by Levi &amp; Korsinsky LLP. Levi &amp; Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi &amp; Korsinsky has ranked in ISS Securities Class Action Services&#8217; Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <strong>Frequently Asked Questions About the PODD Lawsuit<\/strong>\n      <\/p>\n<p>\n        <strong>Q: What specific misstatements does the PODD lawsuit allege?<\/strong> A: The complaint alleges Insulet Corporation made materially false or misleading statements regarding its manufacturing quality controls, product safety, and the scope of defects in its Omnipod insulin delivery systems during the Class Period from February 21, 2025 through May 26, 2026. When two Medical Device Corrections revealed systemic cannula tear defects, the stock price declined sharply.<\/p>\n<p>\n        <strong>Q: How much did PODD stock drop?<\/strong> A: Shares fell approximately 6.88% ($16.23 per share) after the first recall on March 12, 2026, and an additional 5.07% ($7.79 per share) after the second recall on May 26, 2026. Cumulatively, PODD declined from approximately $236 to $146 per share across the two corrective disclosures.<\/p>\n<p>\n        <strong>Q: What is the PODD lead plaintiff deadline?<\/strong> A: The deadline to apply for lead plaintiff appointment is August 31, 2026. This deadline applies only to investors seeking to serve as lead plaintiff. Class members who do not apply may still participate in any recovery without taking action before this date.<\/p>\n<p>\n        <strong>Q: What if I already sold my PODD shares \u2014 can I still recover losses?<\/strong> A: Yes. Eligibility is based on when you purchased, not whether you still hold them. Investors who bought during the Class Period and sold at a loss may still participate.<\/p>\n<p>\n        <strong>Q: What documents do I need to make a claim?<\/strong> A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.<\/p>\n<p>\n        <strong>Q: Do I need to go to court or give testimony?<\/strong> A: No. The overwhelming majority of class members never appear in court or give depositions. You submit a claim form to receive your portion of recovery.<\/p>\n<p>\n        <strong>Q: What does it cost me to participate?<\/strong> A: Nothing. Securities class actions are handled on a pure contingency basis. No upfront fees, no retainer, no out-of-pocket costs.<\/p>\n<p>\n        <strong>Q: What court was the PODD class action filed in?<\/strong> A: The case was filed in the United States District Court for the District of Massachusetts, governed by the Private Securities Litigation Reform Act of 1995.<\/p>\n<p>CONTACT:<\/p>\n<p>Levi &amp; Korsinsky, LLP<\/p>\n<p>Joseph E. Levi, Esq.<\/p>\n<p>33 Whitehall Street, 27th Floor<\/p>\n<p>New York, NY 10004<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=18wAJnaBIkppiiTucLWTV5FwZFxYAZh6Ns02tQWe4QwAJCFQPYOXIiBqxR8YzdSRhEk8BcsWK5Zw0Mp_Ce-dazmzZLHYXiezmeV9taQ5p3Q=\" rel=\"nofollow\" target=\"_blank\"><br \/>\n          <u>jlevi@SueWallSt.com<\/u><br \/>\n        <\/a>\n      <\/p>\n<p>Tel: (888) SueWallSt<\/p>\n<p>Fax: (212) 363-7171<\/p>\n<p>Attorney Advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTE4NiM3ODAwNzIyIzUwMDE2Mzc4Mw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/M2Y1MDg4MGQtNDdhZS00MmRmLTk4ZDMtNDIzMDhlMmU5ZDNkLTUwMDE2Mzc4My0yMDI2LTA4LTI1LWVu\/tiny\/SueWallSt.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Insulet Promoted Its Manufacturing Quality and Omnipod 5 Growth \u2014 Then Two Recalls Affecting 7 Million Pods Revealed Alleged Manufacturing Deficiencies NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) &#8212; SueWallSt notifies investors of an investigation into Insulet Corporation (NASDAQ: PODD). On one side: a CEO declaring Insulet produced &#8220;tens of millions of Pods with high-quality medical-grade quality at consumer electronic scale.&#8221; On the other: approximately 7 million Pods subject to Medical Device Corrections after manufacturing issues created risks of insulin under-delivery, while shareholders watched PODD plummet from $236 to $146 per share. Insulet&#8217;s stock declined approximately $24 per share cumulatively following the two corrective disclosures. The lead plaintiff deadline is August 31, 2026. Find out if you could qualify to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit &#8211; Contact SueWallSt&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-997902","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit - Contact SueWallSt - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit - Contact SueWallSt - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Insulet Promoted Its Manufacturing Quality and Omnipod 5 Growth \u2014 Then Two Recalls Affecting 7 Million Pods Revealed Alleged Manufacturing Deficiencies NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) &#8212; SueWallSt notifies investors of an investigation into Insulet Corporation (NASDAQ: PODD). On one side: a CEO declaring Insulet produced &#8220;tens of millions of Pods with high-quality medical-grade quality at consumer electronic scale.&#8221; On the other: approximately 7 million Pods subject to Medical Device Corrections after manufacturing issues created risks of insulin under-delivery, while shareholders watched PODD plummet from $236 to $146 per share. Insulet&#8217;s stock declined approximately $24 per share cumulatively following the two corrective disclosures. The lead plaintiff deadline is August 31, 2026. Find out if you could qualify to &hellip; Continue reading &quot;PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit &#8211; Contact SueWallSt&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-25T14:18:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTE4NiM3ODAwNzIyIzUwMDE2Mzc4Mw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit &#8211; Contact SueWallSt\",\"datePublished\":\"2026-08-25T14:18:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\\\/\"},\"wordCount\":1137,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNTE4NiM3ODAwNzIyIzUwMDE2Mzc4Mw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\\\/\",\"name\":\"PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit - Contact SueWallSt - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNTE4NiM3ODAwNzIyIzUwMDE2Mzc4Mw==\",\"datePublished\":\"2026-08-25T14:18:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNTE4NiM3ODAwNzIyIzUwMDE2Mzc4Mw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxNTE4NiM3ODAwNzIyIzUwMDE2Mzc4Mw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit &#8211; Contact SueWallSt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit - Contact SueWallSt - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/","og_locale":"en_US","og_type":"article","og_title":"PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit - Contact SueWallSt - Market Newsdesk","og_description":"Insulet Promoted Its Manufacturing Quality and Omnipod 5 Growth \u2014 Then Two Recalls Affecting 7 Million Pods Revealed Alleged Manufacturing Deficiencies NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) &#8212; SueWallSt notifies investors of an investigation into Insulet Corporation (NASDAQ: PODD). On one side: a CEO declaring Insulet produced &#8220;tens of millions of Pods with high-quality medical-grade quality at consumer electronic scale.&#8221; On the other: approximately 7 million Pods subject to Medical Device Corrections after manufacturing issues created risks of insulin under-delivery, while shareholders watched PODD plummet from $236 to $146 per share. Insulet&#8217;s stock declined approximately $24 per share cumulatively following the two corrective disclosures. The lead plaintiff deadline is August 31, 2026. Find out if you could qualify to &hellip; Continue reading \"PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit &#8211; Contact SueWallSt\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-25T14:18:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTE4NiM3ODAwNzIyIzUwMDE2Mzc4Mw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit &#8211; Contact SueWallSt","datePublished":"2026-08-25T14:18:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/"},"wordCount":1137,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTE4NiM3ODAwNzIyIzUwMDE2Mzc4Mw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/","name":"PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit - Contact SueWallSt - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTE4NiM3ODAwNzIyIzUwMDE2Mzc4Mw==","datePublished":"2026-08-25T14:18:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTE4NiM3ODAwNzIyIzUwMDE2Mzc4Mw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxNTE4NiM3ODAwNzIyIzUwMDE2Mzc4Mw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/podd-shareholder-alert-investors-with-losses-may-seek-to-lead-the-class-action-in-insulet-corporation-securities-lawsuit-contact-suewallst\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PODD Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Insulet Corporation Securities Lawsuit &#8211; Contact SueWallSt"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/997902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=997902"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/997902\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=997902"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=997902"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=997902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}